Patexia Interest Groups

Biology > Nova Content

Written by: Jason J. Jardine & Phillip J. Minnick On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved... Read More »
  Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule... Read More »
Written by: Brianne M. Kingery & Robert J. Hilton, Ph.D. In a recent precedential opinion, the Court of Appeals for the Federal... Read More »
Written by: Makoto Tsunozaki, Ph.D. & Jane Dai, Ph.D. Manufacturers of e-cigarettes find themselves in a challenging regulatory... Read More »
Written by: Alistair J. McIntyre & Jason J. Jardine On September 26, 2023, Nexus Pharmaceuticals, LLC[1] announced[2] that it had... Read More »
Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit... Read More »
Written by: Ari Feinstein & Jane Dai, Ph.D. On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC... Read More »
Written by: Kenneth McNeill & Daniel P. Hughes INCEPT LLC v. PALETTE LIFE SCIENCES, INC. Before Newman, Schall, and... Read More »
Written by: Zachary B. Messick & Brenden S. Gingrich, Ph.D. As retailers or distributors that are not manufacturers of a product... Read More »
Written by: Cesar A. Estrada & Jeremy Anapol INGURAN, LLC, DBA STGENETICS v. ABS GLOBAL, INC., GENUS PLC Before Lourie... Read More »
Written by: Rhett D. Ramsey & Michael L. Fuller In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the... Read More »
Written by: Brianne M. Kingery & Eric Furman, Ph.D. On June 6, 2023, Merck & Co. filed a lawsuit against the U.S. government... Read More »
Promosome LLC, a biotech firm represented by law firm Susman Godfrey, has just filed a patent infringement lawsuits against Moderna... Read More »
Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA)... Read More »
Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has... Read More »
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal and patent... Read More »
Written by:Nima Zargari, Ph.D.  & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
Written by: Alistair J. McIntyre & Jane Dai, Ph.D.   On April 21, 2023, the Supreme Court granted a ... Read More »
Written by: Blake A. Winn & Jason J. Jardine The “Orange Book”, more formally known as Approved Drug Products with... Read More »
Written by: Ashley C. Morales & Michael L. Fuller In ChromaDex, Inc. v Elysium Health, Inc., Appeal No. 2022-1116, the Federal... Read More »